Detalles de la búsqueda
1.
Efficacy, safety and cost per responder of biologics in the treatment of non-radiographic axial spondyloarthritis.
Clin Exp Rheumatol
; 34(5): 935-940, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27385374
2.
Expert Insights from a Delphi-driven Neurologists' Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy.
J Neuromuscul Dis
; 11(2): 411-423, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306059
3.
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion.
Nat Commun
; 15(1): 828, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280853
4.
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
PLoS One
; 18(8): e0289828, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561741
5.
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses.
Sci Signal
; 16(816): eade0326, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113337
6.
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML.
Oncogene
; 41(6): 878-894, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34862459
7.
Number needed to treat for interleukin inhibitors approved for the treatment of moderate-to-severe plaque psoriasis in Italy.
Glob Reg Health Technol Assess
; 8: 53-57, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627878
8.
Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still's Disease.
Glob Reg Health Technol Assess
; 7: 91, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-36643911
9.
MicroRNA-222 Regulates Melanoma Plasticity.
J Clin Med
; 9(8)2020 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32784455
10.
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation.
Sci Adv
; 6(15): eaax2746, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32284990
11.
Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
Clin Drug Investig
; 29(11): 693-702, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19813772
12.
Costo per NNT di upadacitinib nel trattamento dei pazienti con dermatite atopica da moderata a severa in Italia.
Glob Reg Health Technol Assess
; 11: 38-50, 2024.
Artículo
en Italiano
| MEDLINE | ID: mdl-38380163
13.
Costo per Number Needed to Treat (NNT) di upadacitinib nel trattamento dei pazienti bio-exposed con rettocolite ulcerosa attiva da moderata a grave.
Glob Reg Health Technol Assess
; 11: 55-67, 2024.
Artículo
en Italiano
| MEDLINE | ID: mdl-38469393
14.
Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma.
Clin Drug Investig
; 28(1): 55-65, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18081361
15.
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting.
Clin Drug Investig
; 28(10): 645-55, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18783303
16.
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate.
Clinicoecon Outcomes Res
; 9: 403-410, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28765712
17.
Il costo a carico dei pazienti del percorso per eleggibilità ai farmaci PCSK9 e follow-up di un anno: i risultati dello Studio PRIOR.
Glob Reg Health Technol Assess
; 9: 73-81, 2022.
Artículo
en Italiano
| MEDLINE | ID: mdl-36628306
18.
Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy.
Glob Reg Health Technol Assess
; 9: 30, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36628313
19.
Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database.
Clinicoecon Outcomes Res
; 9: 711-720, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29200880
20.
Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy.
Clinicoecon Outcomes Res
; 9: 9-17, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28053549